Cargando…
IL-33 Enhances ACE2 Expression on Epidermal Keratinocytes in Atopic Dermatitis: A Plausible Issue for SARS-CoV-2 Transmission in Inflamed Atopic Skin
Background: Interleukin-33 (IL-33) is an important cytokine in the pathophysiology of atopic dermatitis (AD) and in the progression of COVID-19. Angiotensin converting enzyme 2 (ACE2), the entry receptor for SARS-CoV-2, is expressed in epidermal keratinocytes. Whether IL-33 could regulate the expres...
Autores principales: | Lin, En-Cheng, Hong, Chien-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138833/ https://www.ncbi.nlm.nih.gov/pubmed/35625919 http://dx.doi.org/10.3390/biomedicines10051183 |
Ejemplares similares
-
Keratinocytes: An Enigmatic Factor in Atopic Dermatitis
por: Das, Pamelika, et al.
Publicado: (2022) -
Epidermal Barrier in Atopic Dermatitis
por: Kim, Byung Eui, et al.
Publicado: (2012) -
ΔNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis
por: Rizzo, J M, et al.
Publicado: (2016) -
Role of Staphylococcal Superantigen in Atopic Dermatitis: Influence on Keratinocytes
por: Kim, Kyu Han, et al.
Publicado: (2006) -
A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
por: Salimi, Maryam, et al.
Publicado: (2013)